For Business Development Professionals

BioMotiv is developing a portfolio of novel therapeutics based on technologies licensed from research institutions and industry sources.

For Innovators

BioMotiv is a therapeutic accelerator developing a portfolio of new medicines.  We are interested in all disease areas and types of therapeutics. Innovators can submit technologies for consideration here.

/// Recent News
The Harrington Discovery Institute at University Hospitals Case Medical Center has chosen the first 10 doctors it will support as they develop drugs to treat Alzheimer's disease, prevent breast and ovarian cancer, reduce cell damage after a heart attack and more.



 
Click to view more
/// Pipeline

The company is interested in all disease areas and types of therapeutics—small molecules, antibodies, proteins, cell therapies, and nucleotides.  BioMotiv is sourcing products from the discovery to pre-clinical stages of development, and also consider drug repurposing opportunities.


Click to view more

 

 

 

/// The Harrington Project
The Harrington Project for Discovery & Development is a $250 million national initiative to support the discovery and development of therapeutic breakthroughs by physician-scientists.  The Project is a new and powerful national model that addresses a set of major challenges in advancing medicine.

Click to view more